Centiva Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,795	Closed	-$758K	–	1172
2025 Q2	$758K	Buy	+13,795	New	+$812K	0.05%	750
2025 Q1	–	Sell	-3,544	Closed	-$233K	–	1587
2024 Q4	$233K	Sell	3,544 -3,967	-53%	-$266K	0.01%	1293
2024 Q3	$528K	Buy	+7,511	New	+$628K	0.02%	1222
2024 Q2	–	Sell	-2,630	Closed	-$230K	–	2082
2024 Q1	$230K	Buy	+2,630	New	+$235K	0.01%	1400
2023 Q3	–	Sell	-2,341	Closed	-$203K	–	1735
2023 Q2	$203K	Buy	2,341 +251	+12%	+$23.6K	0.01%	1332
2023 Q1	$203K	Sell	2,090 -20,985	-91%	-$2.18M	0.01%	1230
2022 Q4	$2.39M	Sell	23,075 -9,863	-30%	-$926K	0.2%	299
2022 Q3	$2.79M	Buy	32,938 +2,728	+9%	+$243K	0.21%	276
2022 Q2	$2.5M	Buy	30,210 +4,460	+17%	+$355K	0.14%	304
2022 Q1	$1.99M	Buy	+25,750	New	+$2.15M	0.11%	440
2021 Q4	–	Sell	-29,301	Closed	-$2.26M	–	1225
2021 Q3	$2.26M	Sell	29,301 -7,817	-21%	-$617K	0.18%	150
2021 Q2	$3.1M	Sell	37,118 -4,288	-10%	-$340K	0.24%	215
2021 Q1	$3.13M	Buy	41,406 +11,106	+37%	+$907K	0.43%	122
2020 Q4	$2.66M	Buy	+30,300	New	+$2.4M	0.34%	117
2020 Q1	–	Sell	-2,397	Closed	-$203K	–	640
2019 Q4	$203K	Buy	+2,397	New	+$181K	0.03%	669